Basal cell carcinoma and squamous cell carcinoma are the two most common types of non-melanoma skin cancer. These cancers begin in different layers of the skin.

In a phase 3, randomized trial, we enrolled patients with local or regional cutaneous squamous-cell carcinoma, after surgical resection and postoperative radiotherapy, at high risk for recurrence ...

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC ...

A patient recounts his squamous cell carcinoma diagnosis, treatment and recovery, emphasizing self-advocacy in navigating the medical system. It was a Friday afternoon, and I was sitting in ...

The sBLA is supported by data from the phase 3 KEYNOTE-689 which evaluated pembrolizumab in an estimated 704 treatment-naïve patients.

Squamous cell carcinoma of the lip often develops from a precancerous lesion called actinic cheilitis. Both conditions can cause changes in the color and texture of your lip. Your outlook is best ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...